TOPANWIN DAFTAR - AN OVERVIEW

Only one troponin assay should be utilised provided the heterogeneity of assays. This is especially important for multicentre trials.The release of cTn is agnostic to the cause of myocardial harm. Why the vast majority of the healthy population has quantifiable cTn of their peripheral blood (based upon higher-sensitivity assays) remains an enigma.